FTY720 down-regulated the active form of RhoA in pancreatic cancer cells 53, reduced levels of active Rac in hepatocellular carcinoma 78,79 as well as decreasing levels of ROBO1 and ROCK1 (targets of RhoA) in glioblastoma cells. This evidence concerns the gene RHOA and pancreatic neoplasm.